J. Schütte

4.5k total citations
76 papers, 2.7k citations indexed

About

J. Schütte is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J. Schütte has authored 76 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in J. Schütte's work include Gastrointestinal Tumor Research and Treatment (16 papers), Sarcoma Diagnosis and Treatment (14 papers) and Gastric Cancer Management and Outcomes (11 papers). J. Schütte is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (16 papers), Sarcoma Diagnosis and Treatment (14 papers) and Gastric Cancer Management and Outcomes (11 papers). J. Schütte collaborates with scholars based in Germany, United States and United Kingdom. J. Schütte's co-authors include J D Minna, S. Seeber, M. J. Birrer, Jean Viallet, Marion M. Nau, Shoshana Segal, J Fedorko, Sebastian Bauer, N. Niederle and Michael Flaßhove and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

J. Schütte

70 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Schütte Germany 27 1.1k 914 889 549 386 76 2.7k
Janusz A. Siedlecki Poland 30 1.1k 1.0× 918 1.0× 463 0.5× 755 1.4× 600 1.6× 124 2.7k
Sabrina Rossi Italy 24 1.0k 0.9× 1.0k 1.1× 636 0.7× 561 1.0× 478 1.2× 55 2.5k
Paolo Bianchi Italy 30 752 0.7× 409 0.4× 1.5k 1.7× 352 0.6× 484 1.3× 76 3.1k
Anna Maria Chiaravalli Italy 30 447 0.4× 737 0.8× 990 1.1× 437 0.8× 963 2.5× 82 2.5k
Teresa S. Kim United States 22 648 0.6× 341 0.4× 1.1k 1.3× 207 0.4× 236 0.6× 47 2.1k
Elisa Rossi Italy 25 581 0.5× 374 0.4× 546 0.6× 73 0.1× 421 1.1× 78 1.8k
Hiroyuki Yanai Japan 25 624 0.6× 563 0.6× 490 0.6× 74 0.1× 386 1.0× 148 2.0k
Akiko Kunita Japan 31 1.1k 1.0× 509 0.6× 1.9k 2.1× 76 0.1× 997 2.6× 60 3.2k
Yin Luo Italy 17 946 0.8× 99 0.1× 564 0.6× 118 0.2× 1.0k 2.7× 33 2.9k
Chantal Desmaze France 23 2.6k 2.3× 2.1k 2.3× 842 0.9× 37 0.1× 247 0.6× 43 4.5k

Countries citing papers authored by J. Schütte

Since Specialization
Citations

This map shows the geographic impact of J. Schütte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Schütte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Schütte more than expected).

Fields of papers citing papers by J. Schütte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Schütte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Schütte. The network helps show where J. Schütte may publish in the future.

Co-authorship network of co-authors of J. Schütte

This figure shows the co-authorship network connecting the top 25 collaborators of J. Schütte. A scholar is included among the top collaborators of J. Schütte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Schütte. J. Schütte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schütte, J., et al.. (2024). Remission of longstanding metastatic paraganglioma in a patient after use of zoledronic acid. BMJ Case Reports. 17(11). e262628–e262628.
2.
Schmitt, Thomas, Regine Mayer‐Steinacker, Frank Mayer, et al.. (2016). Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO). European Journal of Cancer. 64. 74–82. 32 indexed citations
3.
Rathmann, Nils, Steffen J. Diehl, Dietmar Dinter, et al.. (2014). Radioembolization in Patients with Progressive Gastrointestinal Stromal Tumor Liver Metastases Undergoing Treatment with Tyrosine Kinase Inhibitors. Journal of Vascular and Interventional Radiology. 26(2). 231–238. 13 indexed citations
4.
Schüler, Martin, Ahmad Awada, Philipp Harter, et al.. (2012). A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment. 134(3). 1149–1159. 71 indexed citations
5.
Schütte, J., Georgios Stamatis, G. Taeger, & Karl Hartmann. (2009). Weichteilsarkome des Erwachsenen. PUBLISSO (German National Library of Medicine). 4(2). 16–34. 1 indexed citations
6.
Capri, Giuseppe, José Chang, Pierfranco Conté, et al.. (2009). An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer. Annals of Oncology. 21(3). 474–480. 64 indexed citations
7.
Montemurro, Michael, Patrick Schöffski, Peter Reichardt, et al.. (2009). Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. European Journal of Cancer. 45(13). 2293–2297. 109 indexed citations
8.
Bauer, Sebastian, Christopher L. Corless, Michael C. Heinrich, et al.. (2003). Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT. Cancer Chemotherapy and Pharmacology. 51(3). 261–265. 57 indexed citations
9.
Siprashvili, Zurab, Louise Y.Y. Fong, G. Marquitan, et al.. (2000). Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.. PubMed. 60(11). 2780–5. 38 indexed citations
10.
Eberhardt, Wilfried, Georgios Stamatis, Martin Stuschke, et al.. (1999). Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: Long-term results of a phase II trial. British Journal of Cancer. 81(7). 1206–1212. 71 indexed citations
11.
Marquitan, G., et al.. (1999). Novel Tumor Suppressor Locus in Human Chromosome Region 3p14.2. JNCI Journal of the National Cancer Institute. 91(18). 1563–1568. 15 indexed citations
13.
Belair, Cassandra D., et al.. (1998). Minimal deletion of 3p13→14.2 associated with immortalization of human uroepithelial cells. Genes Chromosomes and Cancer. 21(1). 39–48. 21 indexed citations
14.
Seeber, S. & J. Schütte. (1998). Therapiekonzepte Onkologie. 2 indexed citations
15.
Schütte, J., et al.. (1993). Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.. PubMed. 31 Suppl 2. S194–8. 12 indexed citations
16.
Schütte, J. & S. Seeber. (1993). Bombesin Antagonists: Experimental and Clinical Results. Recent results in cancer research. 129. 115–129. 2 indexed citations
17.
Schütte, J., Bertram Opalka, R. Becher, et al.. (1993). Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia. Leukemia Research. 17(6). 533–539. 22 indexed citations
18.
Schütte, J., Henning T. Mouridsen, Wendy A. Stewart, et al.. (1990). Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. European Journal of Cancer and Clinical Oncology. 26(5). 558–561. 74 indexed citations
19.
Schütte, J., Jean Viallet, Marion M. Nau, et al.. (1989). jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell. 59(6). 987–997. 429 indexed citations
20.
Schulz, Knud & J. Schütte. (1960). Multiple acanthoma in the skin of swine.. 31. 437–442. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026